A data-driven network model of primary myelofibrosis: transcriptional and post-transcriptional alterations in CD34+ cells-Reference-Cited by-同舟云学术

A data-driven network model of primary myelofibrosis: transcriptional and post-transcriptional alterations in CD34+ cells

Published:2016-06 Issue:6 Volume:6 Page:e439-e439
ISSN:2044-5385
Container-title:Blood Cancer Journal
language:en
Short-container-title:Blood Cancer Journal

Author:

Calura E, ,Pizzini S^ORCID,Bisognin A,Coppe A,Sales G,Gaffo E,Fanelli T,Mannarelli C,Zini R,Norfo R,Pennucci V,Manfredini R,Romualdi C,Guglielmelli P,Vannucchi A M,Bortoluzzi S

Publisher

Springer Science and Business Media LLC

Subject

Oncology,Hematology

Link

http://www.nature.com/articles/bcj201647.pdf

Reference66 articles.

1. Tefferi A, Vardiman JW . Classification and diagnosis of myeloproliferative neoplasms: the 2008 World Health Organization criteria and point-of-care diagnostic algorithms. Leukemia 2007; 22: 14–22.

2. Vannucchi AM, Guglielmelli P, Tefferi A . Advances in understanding and management of myeloproliferative neoplasms. CA Cancer J Clin 2009; 59: 171–191.

3. Baxter EJ, Scott LM, Campbell PJ, East C, Fourouclas N, Swanton S et al. Acquired mutation of the tyrosine kinase JAK2 in human myeloproliferative disorders. Lancet Lond Engl 2005; 365: 1054–1061.

4. Jones AV, Kreil S, Zoi K, Waghorn K, Curtis C, Zhang L et al. Widespread occurrence of the JAK2 V617F mutation in chronic myeloproliferative disorders. Blood 2005; 106: 2162–2168.

5. Lau WWY, Hannah R, Green AR, Göttgens B . The JAK-STAT signaling pathway is differentially activated in CALR-positive compared with JAK2V617F-positive ET patients. Blood 2015; 125: 1679–1681.

Cited by 15 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. MiR-19b-3p Inhibits Hypoxia-Ischemia Encephalopathy by Inhibiting SOX6 Expression via Activating Wnt/β-catenin Pathway;Neurochemical Research;2022-11-12

2. Overexpression of miR-17 predicts adverse prognosis and disease recurrence for acute myeloid leukemia;International Journal of Clinical Oncology;2022-05-10

3. miRNA bioinformatics and pathway analysis;MicroRNA in Human Malignancies;2022

4. Diagnostic and Therapeutic MicroRNAs in Primary Myelofibrosis;Proceedings of the Singapore National Academy of Science;2020-12

5. Circulating Cell-Free Nucleic Acids as Epigenetic Biomarkers in Precision Medicine;Frontiers in Genetics;2020-08-11